过敏性鼻炎中的生物药物
1Department of Otorhinolaryngology, Faculty of Medicine, Kırıkkale University, Kırıkkale, Turkey. nbayarmuluk@yahoo.com.
European review for medical and pharmacological sciences
|October 23, 2023
概括
像Omalizumab和Dupilumab这样的生物药物显示出对治疗过敏性鼻炎 (AR) 的承诺. 这些先进疗法,包括Anti-IgE和Anti-IL-4/IL-13药物,可以改善AR患者的症状控制和减少药物需求.
科学领域:
- 免疫学和过敏学
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 过敏性鼻炎 (AR) 是一种普遍影响生活质量的疾病.
- 传统的AR治疗有局限性,需要新的治疗方法.
- 生物制剂代表了管理复杂过敏疾病的新前沿.
研究的目的:
- 审查当前关于过敏性鼻炎 (AR) 的生物药物的文献.
- 详细说明特定生物药物的疗效和应用,包括Omalizumab,Dupilumab,Mepolizumab,Reslizumab和Benralizumab.
- 评估这些药物在AR治疗中的作用,特别是在严重或耐火病例中.
主要方法:
- 在PubMed,谷歌学者,EBSCO学术搜索终极和监管机构网站 (FDA,EMA) 上进行全面的文献搜索.
- 包括随机对照试验,安慰剂对照研究,评论,元分析和2000-2021年的报告.
- 关键词包括"过敏性鼻炎"",生物制剂"",特定药物名称"和抗体标 (例如,抗IgE,抗IL-4/IL-13,抗IL-5).
主要成果:
- 奥马利祖马布 (Anti-IgE) 改善了鼻腔救援药物评分,并减少了AR和犀牛结膜炎的抗过敏药物使用.
- 奥马利祖马布还在免疫治疗期间减轻过敏反应方面发挥了作用.
- 杜皮卢马布 (Anti-IL-4/IL-13) 在多年性AR中显著改善了鼻鼻结局.
- 抗IL-5药物 (Mepolizumab,Reslizumab,Benralizumab) 可降低乙氨基和皮质类固醇依赖,主要用于严重的乙氨基性喘.
结论:
- 生物药物,特别是Omalizumab和Dupilumab,正在成为过敏性鼻炎的有价值的治疗选择.
- 这些药物提供有针对性的作用机制,针对AR的特定炎症途径.
- 预计进一步的研究和临床应用将扩大AR管理中的生物药物的使用.
更多相关视频
03:40Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
517
11:54Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples
Published on: January 21, 2018
30.4K
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
312
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
312
01:17Drugs Used in Lower Respiratory Disorders: Overview
458
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
458
01:16Drugs Used in Upper Respiratory Disorders: Overview
265
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
265
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
273
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
273
01:19Antiasthma Drugs: Leukotriene Modifiers
324
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
324
01:27Allergic Drug Reactions
852
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
852